Silence Therapeutics has appointed Michael Khan as its new chief medical adviser. He will also serve on the company's board of directors.
Khan is an associate professor of medicine at the University of Warwick.
Silence Therapeutics has appointed Michael Khan as its new chief medical adviser. He will also serve on the company's board of directors.
Khan is an associate professor of medicine at the University of Warwick.